🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Bradley D. Hunter

Intermountain Healthcare

ORCID: 0000-0001-9184-2737

Also affiliated with LDS Hospital

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA)”.

Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA)

EClinicalMedicine(2022)10.1016/j.eclinm.2022.101409

N/A

1.1DataRank · unranked

37 citations

Norbert Bräu, Michael R. Waters, Ronaldo C. Go, Atul Malhotra, Bradley D. Hunter +32 more

Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study

The Lancet Rheumatology(2020)10.1016/s2665-9913(20)30343-x

N/A

0DataRank · unranked

310 citations

Ithan D. Peltan, Paul N. Jensen, Daanish Hoda, Bradley D. Hunter, Aaron E. Silver +10 more

CRS or ICANS Are Rare Beyond 2 Weeks After Lisocabtagene Maraleucel Infusion: Data From Clinical Trials and the Real-World Setting

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.10.024

N/A

0DataRank · unranked

3 citations

Matthew A. Lunning, Mazyar Shadman, Sairah Ahmed, Jeremy S. Abramson, Miguel‐Angel Perales +14 more